nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—CYP2D6—Fingolimod—multiple sclerosis	0.103	0.137	CbGbCtD
Epinastine—ABCB1—Methylprednisolone—multiple sclerosis	0.0703	0.0939	CbGbCtD
Epinastine—CYP3A4—Fingolimod—multiple sclerosis	0.0653	0.0873	CbGbCtD
Epinastine—CYP2B6—Dexamethasone—multiple sclerosis	0.0518	0.0693	CbGbCtD
Epinastine—ABCB1—Mitoxantrone—multiple sclerosis	0.0513	0.0685	CbGbCtD
Epinastine—ABCB1—Betamethasone—multiple sclerosis	0.0457	0.0611	CbGbCtD
Epinastine—ABCB1—Prednisolone—multiple sclerosis	0.0451	0.0602	CbGbCtD
Epinastine—ABCB1—Prednisone—multiple sclerosis	0.0426	0.0569	CbGbCtD
Epinastine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0421	0.0563	CbGbCtD
Epinastine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0324	0.242	CbGeAlD
Epinastine—CYP3A4—Triamcinolone—multiple sclerosis	0.0319	0.0426	CbGbCtD
Epinastine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0307	0.041	CbGbCtD
Epinastine—CYP3A4—Betamethasone—multiple sclerosis	0.0274	0.0366	CbGbCtD
Epinastine—CYP3A4—Prednisolone—multiple sclerosis	0.027	0.0361	CbGbCtD
Epinastine—ABCB1—Dexamethasone—multiple sclerosis	0.0266	0.0355	CbGbCtD
Epinastine—CYP3A4—Prednisone—multiple sclerosis	0.0255	0.0341	CbGbCtD
Epinastine—CYP2D6—Dexamethasone—multiple sclerosis	0.025	0.0335	CbGbCtD
Epinastine—ABCB1—Methotrexate—multiple sclerosis	0.0214	0.0285	CbGbCtD
Epinastine—CYP3A4—Dexamethasone—multiple sclerosis	0.0159	0.0213	CbGbCtD
Epinastine—HTR7—pons—multiple sclerosis	0.0096	0.0717	CbGeAlD
Epinastine—HTR2A—trigeminal nerve—multiple sclerosis	0.0085	0.0635	CbGeAlD
Epinastine—HTR7—peripheral nervous system—multiple sclerosis	0.00638	0.0477	CbGeAlD
Epinastine—HTR2A—pons—multiple sclerosis	0.00598	0.0447	CbGeAlD
Epinastine—HTR7—nerve—multiple sclerosis	0.00498	0.0372	CbGeAlD
Epinastine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00468	0.035	CbGeAlD
Epinastine—HTR2A—pineal body—multiple sclerosis	0.00427	0.0319	CbGeAlD
Epinastine—HTR2A—peripheral nervous system—multiple sclerosis	0.00398	0.0298	CbGeAlD
Epinastine—HTR2A—nerve—multiple sclerosis	0.0031	0.0232	CbGeAlD
Epinastine—HRH2—nervous system—multiple sclerosis	0.0022	0.0165	CbGeAlD
Epinastine—HTR7—brainstem—multiple sclerosis	0.00214	0.016	CbGeAlD
Epinastine—HRH2—central nervous system—multiple sclerosis	0.00212	0.0158	CbGeAlD
Epinastine—ADRA1A—brainstem—multiple sclerosis	0.00206	0.0154	CbGeAlD
Epinastine—HRH2—brain—multiple sclerosis	0.00168	0.0126	CbGeAlD
Epinastine—HTR7—medulla oblongata—multiple sclerosis	0.00149	0.0111	CbGeAlD
Epinastine—HTR7—midbrain—multiple sclerosis	0.00136	0.0102	CbGeAlD
Epinastine—HTR2A—brainstem—multiple sclerosis	0.00133	0.00996	CbGeAlD
Epinastine—HTR7—spinal cord—multiple sclerosis	0.00133	0.00993	CbGeAlD
Epinastine—HTR2A—retina—multiple sclerosis	0.00129	0.00961	CbGeAlD
Epinastine—CYP2D6—brainstem—multiple sclerosis	0.00121	0.00907	CbGeAlD
Epinastine—Hyperaemia—Betamethasone—multiple sclerosis	0.00118	0.0932	CcSEcCtD
Epinastine—Hyperaemia—Dexamethasone—multiple sclerosis	0.00118	0.0932	CcSEcCtD
Epinastine—HTR7—nervous system—multiple sclerosis	0.00112	0.00837	CbGeAlD
Epinastine—ADRA2A—medulla oblongata—multiple sclerosis	0.00109	0.00817	CbGeAlD
Epinastine—ADRA1A—nervous system—multiple sclerosis	0.00108	0.00807	CbGeAlD
Epinastine—HTR7—central nervous system—multiple sclerosis	0.00108	0.00805	CbGeAlD
Epinastine—HTR7—cerebellum—multiple sclerosis	0.00105	0.00787	CbGeAlD
Epinastine—ADRA1A—central nervous system—multiple sclerosis	0.00104	0.00777	CbGeAlD
Epinastine—ADRA1A—cerebellum—multiple sclerosis	0.00102	0.00759	CbGeAlD
Epinastine—ADRA2A—midbrain—multiple sclerosis	0.000999	0.00746	CbGeAlD
Epinastine—ADRA2A—spinal cord—multiple sclerosis	0.000974	0.00728	CbGeAlD
Epinastine—HTR2A—medulla oblongata—multiple sclerosis	0.000929	0.00694	CbGeAlD
Epinastine—CYP2B6—nervous system—multiple sclerosis	0.000856	0.0064	CbGeAlD
Epinastine—HTR7—brain—multiple sclerosis	0.000856	0.00639	CbGeAlD
Epinastine—HTR2A—midbrain—multiple sclerosis	0.000849	0.00635	CbGeAlD
Epinastine—ABCB1—retina—multiple sclerosis	0.000842	0.00629	CbGeAlD
Epinastine—HRH1—nervous system—multiple sclerosis	0.000836	0.00625	CbGeAlD
Epinastine—HTR2A—spinal cord—multiple sclerosis	0.000828	0.00619	CbGeAlD
Epinastine—ADRA1A—brain—multiple sclerosis	0.000825	0.00617	CbGeAlD
Epinastine—CYP2B6—central nervous system—multiple sclerosis	0.000824	0.00616	CbGeAlD
Epinastine—ADRA2A—nervous system—multiple sclerosis	0.000821	0.00614	CbGeAlD
Epinastine—HRH1—central nervous system—multiple sclerosis	0.000805	0.00601	CbGeAlD
Epinastine—ADRA2A—central nervous system—multiple sclerosis	0.00079	0.00591	CbGeAlD
Epinastine—ADRA2A—cerebellum—multiple sclerosis	0.000773	0.00577	CbGeAlD
Epinastine—Sinusitis—Fingolimod—multiple sclerosis	0.000731	0.0579	CcSEcCtD
Epinastine—HTR2A—nervous system—multiple sclerosis	0.000698	0.00522	CbGeAlD
Epinastine—HTR2A—central nervous system—multiple sclerosis	0.000672	0.00502	CbGeAlD
Epinastine—HTR2A—cerebellum—multiple sclerosis	0.000657	0.00491	CbGeAlD
Epinastine—CYP2B6—brain—multiple sclerosis	0.000654	0.00489	CbGeAlD
Epinastine—CYP3A4—nervous system—multiple sclerosis	0.000646	0.00483	CbGeAlD
Epinastine—HRH1—brain—multiple sclerosis	0.000639	0.00477	CbGeAlD
Epinastine—CYP2D6—nervous system—multiple sclerosis	0.000636	0.00475	CbGeAlD
Epinastine—ADRA2A—brain—multiple sclerosis	0.000628	0.00469	CbGeAlD
Epinastine—CYP3A4—central nervous system—multiple sclerosis	0.000622	0.00465	CbGeAlD
Epinastine—CYP2D6—central nervous system—multiple sclerosis	0.000612	0.00458	CbGeAlD
Epinastine—ABCB1—medulla oblongata—multiple sclerosis	0.000609	0.00455	CbGeAlD
Epinastine—CYP2D6—cerebellum—multiple sclerosis	0.000598	0.00447	CbGeAlD
Epinastine—ABCB1—midbrain—multiple sclerosis	0.000556	0.00416	CbGeAlD
Epinastine—ABCB1—spinal cord—multiple sclerosis	0.000543	0.00406	CbGeAlD
Epinastine—HTR2A—brain—multiple sclerosis	0.000534	0.00399	CbGeAlD
Epinastine—Cough—Fingolimod—multiple sclerosis	0.000531	0.0421	CcSEcCtD
Epinastine—Eye irritation—Prednisolone—multiple sclerosis	0.000498	0.0395	CcSEcCtD
Epinastine—Infection—Fingolimod—multiple sclerosis	0.000493	0.0391	CcSEcCtD
Epinastine—CYP2D6—brain—multiple sclerosis	0.000486	0.00363	CbGeAlD
Epinastine—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00046	0.0365	CcSEcCtD
Epinastine—ABCB1—nervous system—multiple sclerosis	0.000457	0.00342	CbGeAlD
Epinastine—ABCB1—central nervous system—multiple sclerosis	0.00044	0.00329	CbGeAlD
Epinastine—ABCB1—cerebellum—multiple sclerosis	0.00043	0.00322	CbGeAlD
Epinastine—Cough increased—Triamcinolone—multiple sclerosis	0.000427	0.0339	CcSEcCtD
Epinastine—Pharyngitis—Cladribine—multiple sclerosis	0.000393	0.0312	CcSEcCtD
Epinastine—Pruritus—Fingolimod—multiple sclerosis	0.000351	0.0278	CcSEcCtD
Epinastine—ABCB1—brain—multiple sclerosis	0.00035	0.00261	CbGeAlD
Epinastine—Headache—Fingolimod—multiple sclerosis	0.000311	0.0247	CcSEcCtD
Epinastine—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.000302	0.024	CcSEcCtD
Epinastine—Cough—Cladribine—multiple sclerosis	0.000301	0.0239	CcSEcCtD
Epinastine—Infection—Cladribine—multiple sclerosis	0.00028	0.0222	CcSEcCtD
Epinastine—Sinusitis—Mitoxantrone—multiple sclerosis	0.000272	0.0216	CcSEcCtD
Epinastine—Rhinitis—Mitoxantrone—multiple sclerosis	0.000261	0.0207	CcSEcCtD
Epinastine—Pharyngitis—Mitoxantrone—multiple sclerosis	0.000259	0.0205	CcSEcCtD
Epinastine—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.000228	0.0181	CcSEcCtD
Epinastine—Infection—Azathioprine—multiple sclerosis	0.000227	0.018	CcSEcCtD
Epinastine—Pruritus—Cladribine—multiple sclerosis	0.000199	0.0158	CcSEcCtD
Epinastine—Cough—Mitoxantrone—multiple sclerosis	0.000198	0.0157	CcSEcCtD
Epinastine—Rhinitis—Triamcinolone—multiple sclerosis	0.000197	0.0156	CcSEcCtD
Epinastine—Rhinitis—Methylprednisolone—multiple sclerosis	0.000197	0.0156	CcSEcCtD
Epinastine—Pharyngitis—Triamcinolone—multiple sclerosis	0.000195	0.0155	CcSEcCtD
Epinastine—Infection—Mitoxantrone—multiple sclerosis	0.000184	0.0146	CcSEcCtD
Epinastine—Headache—Cladribine—multiple sclerosis	0.000176	0.014	CcSEcCtD
Epinastine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000151	0.0119	CcSEcCtD
Epinastine—Cough—Triamcinolone—multiple sclerosis	0.000149	0.0118	CcSEcCtD
Epinastine—Headache—Azathioprine—multiple sclerosis	0.000143	0.0114	CcSEcCtD
Epinastine—Infection—Triamcinolone—multiple sclerosis	0.000139	0.011	CcSEcCtD
Epinastine—Infection—Methylprednisolone—multiple sclerosis	0.000138	0.011	CcSEcCtD
Epinastine—Pharyngitis—Methotrexate—multiple sclerosis	0.000129	0.0102	CcSEcCtD
Epinastine—Infection—Betamethasone—multiple sclerosis	0.000126	0.00997	CcSEcCtD
Epinastine—Infection—Dexamethasone—multiple sclerosis	0.000126	0.00997	CcSEcCtD
Epinastine—Headache—Mitoxantrone—multiple sclerosis	0.000116	0.00919	CcSEcCtD
Epinastine—Infection—Prednisone—multiple sclerosis	0.00011	0.00869	CcSEcCtD
Epinastine—Pruritus—Triamcinolone—multiple sclerosis	9.88e-05	0.00783	CcSEcCtD
Epinastine—Cough—Methotrexate—multiple sclerosis	9.86e-05	0.00781	CcSEcCtD
Epinastine—Pruritus—Methylprednisolone—multiple sclerosis	9.86e-05	0.00781	CcSEcCtD
Epinastine—Headache—Prednisolone—multiple sclerosis	9.51e-05	0.00754	CcSEcCtD
Epinastine—Infection—Methotrexate—multiple sclerosis	9.16e-05	0.00726	CcSEcCtD
Epinastine—Pruritus—Betamethasone—multiple sclerosis	8.96e-05	0.0071	CcSEcCtD
Epinastine—Pruritus—Dexamethasone—multiple sclerosis	8.96e-05	0.0071	CcSEcCtD
Epinastine—Headache—Triamcinolone—multiple sclerosis	8.75e-05	0.00693	CcSEcCtD
Epinastine—Headache—Methylprednisolone—multiple sclerosis	8.73e-05	0.00692	CcSEcCtD
Epinastine—Headache—Dexamethasone—multiple sclerosis	7.94e-05	0.00629	CcSEcCtD
Epinastine—Headache—Betamethasone—multiple sclerosis	7.94e-05	0.00629	CcSEcCtD
Epinastine—Pruritus—Prednisone—multiple sclerosis	7.8e-05	0.00619	CcSEcCtD
Epinastine—Headache—Prednisone—multiple sclerosis	6.91e-05	0.00548	CcSEcCtD
Epinastine—Pruritus—Methotrexate—multiple sclerosis	6.52e-05	0.00517	CcSEcCtD
Epinastine—Headache—Methotrexate—multiple sclerosis	5.78e-05	0.00458	CcSEcCtD
Epinastine—HRH2—Signaling Pathways—CCL5—multiple sclerosis	4.22e-05	0.0004	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.2e-05	0.000398	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CNR1—multiple sclerosis	4.17e-05	0.000396	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	4.11e-05	0.00039	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—IL2—multiple sclerosis	4.09e-05	0.000388	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	4.08e-05	0.000387	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	4.08e-05	0.000387	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	4.07e-05	0.000387	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CXCL10—multiple sclerosis	4.07e-05	0.000386	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	4.06e-05	0.000385	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	3.98e-05	0.000378	CbGpPWpGaD
Epinastine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.95e-05	0.000375	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—SPP1—multiple sclerosis	3.91e-05	0.000371	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	3.86e-05	0.000366	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—POMC—multiple sclerosis	3.85e-05	0.000365	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	3.85e-05	0.000365	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CCR5—multiple sclerosis	3.8e-05	0.000361	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	3.78e-05	0.000358	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CCL2—multiple sclerosis	3.77e-05	0.000358	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CXCL10—multiple sclerosis	3.75e-05	0.000356	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL2RA—multiple sclerosis	3.74e-05	0.000355	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—IL2—multiple sclerosis	3.72e-05	0.000353	CbGpPWpGaD
Epinastine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.7e-05	0.000351	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	3.7e-05	0.000351	CbGpPWpGaD
Epinastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.69e-05	0.000351	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—RRM1—multiple sclerosis	3.69e-05	0.00035	CbGpPWpGaD
Epinastine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.62e-05	0.000344	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—ALB—multiple sclerosis	3.56e-05	0.000338	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	3.51e-05	0.000333	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	3.5e-05	0.000332	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	3.49e-05	0.000332	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.48e-05	0.00033	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	3.47e-05	0.00033	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	3.47e-05	0.000329	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—APOE—multiple sclerosis	3.46e-05	0.000328	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	3.43e-05	0.000325	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	3.42e-05	0.000325	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—TYK2—multiple sclerosis	3.42e-05	0.000325	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.42e-05	0.000324	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.41e-05	0.000323	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	3.4e-05	0.000323	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.4e-05	0.000322	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	3.35e-05	0.000318	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.33e-05	0.000316	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CD86—multiple sclerosis	3.28e-05	0.000311	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCL5—multiple sclerosis	3.23e-05	0.000307	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	3.2e-05	0.000303	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	3.19e-05	0.000303	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	3.19e-05	0.000302	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.17e-05	0.000301	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	3.16e-05	0.0003	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	3.15e-05	0.000299	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	3.15e-05	0.000299	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—IL2—multiple sclerosis	3.13e-05	0.000298	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	3.13e-05	0.000297	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CD80—multiple sclerosis	3.13e-05	0.000297	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	3.11e-05	0.000296	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	3.11e-05	0.000295	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	3.1e-05	0.000294	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	3.09e-05	0.000293	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	3.08e-05	0.000292	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	3.07e-05	0.000291	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—BCHE—multiple sclerosis	3.07e-05	0.000291	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	3.04e-05	0.000289	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PGR—multiple sclerosis	3.03e-05	0.000288	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PGR—multiple sclerosis	3.02e-05	0.000287	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	3.01e-05	0.000286	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3e-05	0.000285	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3e-05	0.000285	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—SPP1—multiple sclerosis	2.99e-05	0.000284	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	2.97e-05	0.000282	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—POMC—multiple sclerosis	2.97e-05	0.000282	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	2.97e-05	0.000282	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	2.97e-05	0.000282	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CD28—multiple sclerosis	2.94e-05	0.000279	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CD28—multiple sclerosis	2.94e-05	0.000279	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCR5—multiple sclerosis	2.91e-05	0.000276	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	2.91e-05	0.000276	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	2.91e-05	0.000276	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CCL2—multiple sclerosis	2.91e-05	0.000276	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	2.89e-05	0.000274	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—IL2—multiple sclerosis	2.89e-05	0.000274	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	2.89e-05	0.000274	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	2.88e-05	0.000274	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.87e-05	0.000273	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	2.87e-05	0.000272	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL2RA—multiple sclerosis	2.87e-05	0.000272	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—IL2—multiple sclerosis	2.85e-05	0.00027	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—MAPK1—multiple sclerosis	2.84e-05	0.00027	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	2.83e-05	0.000269	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	2.83e-05	0.000268	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	2.8e-05	0.000266	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	2.76e-05	0.000262	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.74e-05	0.00026	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	2.71e-05	0.000258	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	2.71e-05	0.000257	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	2.7e-05	0.000257	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	2.68e-05	0.000254	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	2.67e-05	0.000253	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	2.66e-05	0.000253	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	2.66e-05	0.000252	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—APOE—multiple sclerosis	2.65e-05	0.000251	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TYK2—multiple sclerosis	2.64e-05	0.00025	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	2.63e-05	0.00025	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	2.61e-05	0.000248	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	2.47e-05	0.000234	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	2.47e-05	0.000234	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	2.46e-05	0.000233	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	2.43e-05	0.00023	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	2.41e-05	0.000229	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	2.41e-05	0.000229	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	2.41e-05	0.000228	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	2.4e-05	0.000228	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	2.4e-05	0.000228	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CD80—multiple sclerosis	2.39e-05	0.000227	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	2.36e-05	0.000224	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	2.35e-05	0.000223	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—POMC—multiple sclerosis	2.27e-05	0.000216	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.27e-05	0.000216	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	2.25e-05	0.000214	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	2.24e-05	0.000213	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCL2—multiple sclerosis	2.23e-05	0.000211	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	2.21e-05	0.00021	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL2—multiple sclerosis	2.2e-05	0.000208	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	2.19e-05	0.000208	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	2.19e-05	0.000208	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	2.19e-05	0.000207	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	2.19e-05	0.000207	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—IL6—multiple sclerosis	2.18e-05	0.000207	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—MAPK1—multiple sclerosis	2.18e-05	0.000207	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	2.14e-05	0.000204	CbGpPWpGaD
Epinastine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.13e-05	0.000202	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—BCHE—multiple sclerosis	2.12e-05	0.000201	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	2.1e-05	0.000199	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CD86—multiple sclerosis	2.1e-05	0.000199	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MMP9—multiple sclerosis	2.08e-05	0.000197	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	2.07e-05	0.000196	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	2.06e-05	0.000196	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	2.06e-05	0.000195	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	2.03e-05	0.000192	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TYK2—multiple sclerosis	2.02e-05	0.000192	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	2.01e-05	0.00019	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	2e-05	0.00019	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—BCHE—multiple sclerosis	2e-05	0.00019	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.99e-05	0.000189	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.97e-05	0.000187	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.92e-05	0.000182	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.91e-05	0.000181	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.91e-05	0.000181	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.88e-05	0.000179	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.88e-05	0.000178	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.86e-05	0.000177	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.86e-05	0.000176	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—STAT3—multiple sclerosis	1.85e-05	0.000175	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—APOE—multiple sclerosis	1.84e-05	0.000175	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.84e-05	0.000174	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.83e-05	0.000174	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.83e-05	0.000173	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.82e-05	0.000173	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.82e-05	0.000173	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.82e-05	0.000173	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.8e-05	0.000171	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.78e-05	0.000169	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.74e-05	0.000165	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.73e-05	0.000164	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MYC—multiple sclerosis	1.72e-05	0.000163	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TGFB1—multiple sclerosis	1.71e-05	0.000163	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.7e-05	0.000161	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.7e-05	0.000161	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.69e-05	0.000161	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL2—multiple sclerosis	1.68e-05	0.00016	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MAPK1—multiple sclerosis	1.68e-05	0.000159	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—IL6—multiple sclerosis	1.67e-05	0.000159	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.67e-05	0.000159	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.66e-05	0.000158	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.66e-05	0.000157	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MMP9—multiple sclerosis	1.59e-05	0.000151	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.58e-05	0.00015	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.54e-05	0.000146	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.53e-05	0.000145	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.53e-05	0.000145	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.5e-05	0.000142	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—POMC—multiple sclerosis	1.49e-05	0.000141	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.46e-05	0.000138	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.45e-05	0.000138	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.44e-05	0.000137	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.43e-05	0.000135	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.42e-05	0.000135	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.42e-05	0.000135	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—STAT3—multiple sclerosis	1.42e-05	0.000134	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.4e-05	0.000132	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.39e-05	0.000132	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.39e-05	0.000132	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.39e-05	0.000132	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.37e-05	0.00013	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ALB—multiple sclerosis	1.35e-05	0.000129	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.32e-05	0.000126	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MYC—multiple sclerosis	1.32e-05	0.000125	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	1.31e-05	0.000124	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.31e-05	0.000124	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.3e-05	0.000123	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.29e-05	0.000123	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.29e-05	0.000123	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL6—multiple sclerosis	1.29e-05	0.000122	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	1.29e-05	0.000122	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOE—multiple sclerosis	1.28e-05	0.000121	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.27e-05	0.00012	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1.27e-05	0.00012	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.2e-05	0.000114	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.18e-05	0.000112	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—POMC—multiple sclerosis	1.1e-05	0.000104	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	1.08e-05	0.000102	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL2—multiple sclerosis	1.07e-05	0.000102	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	1.07e-05	0.000102	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	1.07e-05	0.000101	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.05e-05	0.0001	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.05e-05	9.95e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—POMC—multiple sclerosis	1.03e-05	9.8e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	1.02e-05	9.67e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	1.02e-05	9.65e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ALB—multiple sclerosis	9.99e-06	9.48e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	9.98e-06	9.47e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL6—multiple sclerosis	9.88e-06	9.38e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	9.8e-06	9.3e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	9.75e-06	9.25e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ALB—multiple sclerosis	9.41e-06	8.93e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	9.27e-06	8.8e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	9.06e-06	8.6e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	9.04e-06	8.58e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	8.87e-06	8.42e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	8.42e-06	7.99e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MYC—multiple sclerosis	8.4e-06	7.97e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	8.4e-06	7.97e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	8.38e-06	7.95e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	8.24e-06	7.82e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	8.24e-06	7.82e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	8.24e-06	7.82e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	8.22e-06	7.8e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	8.22e-06	7.8e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	8.06e-06	7.65e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOE—multiple sclerosis	7.86e-06	7.46e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	7.66e-06	7.27e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	7.64e-06	7.25e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	7.49e-06	7.11e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—POMC—multiple sclerosis	6.75e-06	6.41e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	6.33e-06	6.01e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6—multiple sclerosis	6.31e-06	5.99e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	6.2e-06	5.88e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALB—multiple sclerosis	6.15e-06	5.84e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	5.76e-06	5.46e-05	CbGpPWpGaD
